BRIEF published on 02/25/2026 at 22:20, 7 days 15 hours ago NANOBIOTIX Presents at Key Conferences in March Biotechnology Investor Conferences Cancer Treatments NANOBIOTIX Clinical Advances
BRIEF published on 02/17/2026 at 22:20, 15 days 15 hours ago Nanobiotix Announces Updated Voting Rights and Share Capital Euronext Paris Voting Rights Shares Capital Financial Disclosure NANOBIOTIX
PRESS RELEASE published on 02/17/2026 at 22:15, 15 days 15 hours ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 1 month 3 days ago Goldman Sachs reduces its stake in Nanobiotix Euronext Paris Goldman Sachs Threshold Crossing Transfer Of Shares NANOBIOTIX
BRIEF published on 01/26/2026 at 09:56, 1 month 10 days ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
BRIEF published on 01/13/2026 at 22:20, 1 month 22 days ago Nanobiotix's monthly information on shares and voting rights Voting Rights Euronext Actions Nasdaq NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 1 month 22 days ago Nanobiotix Reports Voting Rights and Share Capital Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE published on 01/13/2026 at 22:15, 1 month 22 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. Listed on Euronext Paris and Nasdaq. Pioneering biotech company with disruptive therapeutic approaches Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 12/15/2025 at 08:35, 2 months 21 days ago NANOBIOTIX to Enter CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology SBF 120 NANOBIOTIX CAC Mid 60
BRIEF published on 12/15/2025 at 08:35, 2 months 21 days ago NANOBIOTIX joins the CAC Mid 60 and SBF 120 indices Investors Biotechnology NANOBIOTIX CAC Mid 60 Stock Market Indices
Published on 03/05/2026 at 13:40, 14 minutes ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 24 minutes ago Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 13:30, 24 minutes ago Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase
Published on 03/05/2026 at 13:00, 54 minutes ago Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico
Published on 03/05/2026 at 13:00, 54 minutes ago Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose
Published on 03/05/2026 at 13:43, 11 minutes ago Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
Published on 03/05/2026 at 13:25, 28 minutes ago Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence
Published on 03/05/2026 at 13:06, 47 minutes ago HENSOLDT acquires Nedinsco and expands its European presence
Published on 03/05/2026 at 13:05, 48 minutes ago Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
Published on 03/05/2026 at 13:00, 53 minutes ago Huawei Launches AI Data Platform to Bridge Models and Business Value
Published on 03/04/2026 at 23:50, 14 hours 4 minutes ago Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 19 hours 53 minutes ago Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 20 hours 9 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
